IGF-I, IGFBP-3 and ALS generation test in Turner syndrome

Growth Hormone and IGF Research

Volumn 17, Issue 3, 2007, Pages 254-260

  Pessoa de Queiroz, Andréa Noronha ^a   Collett Solberg, Paulo F ^a   Cardoso, Monique Esteves ^a   Jusan, Rafaela Cattan ^a   Vaisman, Mario ^a   Guimarães, Marília Martins ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

ALS; Generation test; Growth hormone; IGF I; IGFBP 3; Short stature; Turner syndrome

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; MALE; PREPUBERTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SHORT STATURE; STUDENT T TEST; TURNER SYNDROME;

BODY HEIGHT; CARRIER PROTEINS; CHILD; DWARFISM; FEMALE; GLYCOPROTEINS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; KARYOTYPING; MALE; TURNER SYNDROME;

EID: 34249996528     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.03.003     Document Type: Article

References (37)

1. Saenger P., Albertsson-Wikland K., Conway G.S., et al. Recommendations for the diagnosis and management of Turner syndrome. J. Clin. Endocrinol. Metab. 86 (2001) 3061-3069
2. Gravholt C.H. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur. J. Endocrinol. 151 (2004) 657-687
3. Guimarães M.M., Guerra C.T.G., Alves S.T.F., et al. Intercorrências clínicas na síndrome de Turner. Arq. Bras. Endocrinol. Metab. 45 4 (2001) 331-338
4. Hall J.G., and Gilchrist D.M. Turner's syndrome and its variants. Pediatr. Clin. North. Am. 37 6 (1990) 1421-1437
5. Cuttler L., Vliet G.V., Conte F.A., Kaplan S.L., and Grumbach M.M. Somatomedin-C levels in children and adolescents with gonadal dysgenesis: differences from age-matched normal females and effect of chronic estrogen replacement therapy. J. Clin. Endocrinol. Metab. 60 (1985) 1087-1092
6. Ross J.L., Long L.M., Loriaux D.L., and Cutler Jr. G.B. Growth hormone secretory dynamics in Turner's Syndrome. J. Pediatr. 106 (1985) 202-206
7. Kaplan S.L., Abrams C.A., Bell J.J., Conte F.A., and Grumbach M.M. Growth and growth hormone: changes in serum level of growth hormone following hypoglycemia in 134 children with growth retardation. Pediatr. Res. 2 (1968) 43-63
8. Sanger P. Clinical review 48: The current status of diagnosis and therapeutic intervention in Turner's syndrome. J. Clin. Endocrinol. Metab. 77 2 (1993) 297-301
9. Cappa M., Loche S., Borrelli P., Corda R., Marini R., Porcedda C., and Pintor C. Growth hormone response to growth hormone 1-40 in Turner's Syndrome. Horm. Res. 27 (1987) 1-6
10. Collett-Solberg P.F., and Cohen P. Genetics, chemistry and function of the IGF/IGFBP system. Endocrine 12 (2000) 121-136
11. Kelley K.M., Oh Y., Gargosky S.E., et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int. J. Biochem. Cell Biol. 28 (1996) 619-637
12. Juul A., Moller S., Mosfeldt-Laursen E., et al. The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency. J. Clin. Endocrinol. Metab. 83 (1998) 4408-4415
13. Rosenfeld R.G., Albertsson-Wikland K., Cassorla F., et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J. Clin. Endocrinol. Metab. 80 (1995) 1532-1540
14. Sizonenko P.C., Clayton P.E., Cohen P., Hintz R.L., Tanaka T., and Laron Z. Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency. Growth Horm. IGF Res. 11 (2001) 137-165
15. Laron Z., Pertzelan A., Karp M., Kowadlo-Silbergeld A., and Daughaday W.H. Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: Measurement of sulfatation factor, metabolic and linear growth responses. J. Clin. Endocrinol. Metab. 81 11 (1971) 3902-3908
16. Plotnick L.P., Van Meter Q.L., and Kowarski K.A. Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation. Pediatre 71 3 (1983) 324-327
17. Thalange N.K.S., Price D.A., Gill M.S., Whatmore A.J., Addison G.M., and Clayton P.E. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity. Pediatr. Res. 39 (1996) 849-855
18. Boguszewski M., Jansson C., Rosberg S., and Albertsson-Wikland K. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. J. Clin. Endocrinol. Metab. 81 (1996) 3902-3908
19. Schwarze C.P., Wollmann H.A., Binder G., and Ranke M.B. Short-term increments of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 predict the growth response to growth hormone (GH) therapy in GH-sensitive children. Acta Paediatr. Suppl. 428 (1999) 200-208
20. Buckway C.K., Guevara-Aguirre J., Pratt K.L., Burren C.P., and Rosenfeld R.G. The IGF-I generation test revisited: a marker of GH sensitivity. J. Clin. Endocrinol. Metab. 86 (2001) 5176-5183
21. Blum W.F., Cotterill A.M., Postel-Vinay M.C., Ranke M.B., Savage M.O., and Wilton P. Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Pharmacia study group on insulin-like growth factor I treatment in growth hormone insensitivity syndromes. Acta Paediatr. Suppl. 399 (1994) 117-124
22. Buckway C.K., Selva K.A., Pratt K.L., Tjoeng E., Guevara-Aguirre J., and Rosenfeld R.G. Insulin-like growth factor binding protein-3 generation as a measure of GH sensitivity. J. Clin. Endocrinol. Metab. 87 (2002) 4754-4765
23. Savage M.O., Blum W.F., Ranke M.B., et al. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J. Clin. Endocrinol. Metab. 77 6 (1993) 1465-1471
24. P.V. Hamill, T.A. Drizd, C.L. Johnson, R.B. Reed, A.F. Roche, NCHS growth curves for children, birth-18 years, United States. Vital and Health Statistics series 11. Data from the national health survey, number 165. DHEW Publication number (PHS) 78-1650, National Center for Health Statistics, Hyattsville, 1977.
25. Greulich W.W., and Pyle S.I. Radiographic atlas of skeletal development of the hand and wrist. second ed. (1959), Stanford California Press, Stanford, California
26. Rosenfeld R.G., Tesch L.G., Rodriguez-Rigau L.J., et al. Recommendations for diagnosis treatment, and management of individuals with Turner syndrome. Endocrinologist 4 (1994) 351-358
27. Jorgensen J.O.L., Blum W.F., and Moller N. Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. J. Clin. Endocrinol. Metab. 72 (1991) 582-587
28. Blethen S.L., Daughaday W.H., and Weldon V.V. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children. J. Clin. Endocrinol. Metab. 54 5 (1982) 986-990
29. Valk N.K., vd Lely A.J., de Herder W.W., Lindemans J., and Lamberts S.W. The effect of human growth hormone (GH) administration in GH-deficient adults: a 20-day metabolic ward study. J. Clin. Endocrinol. Metab. 79 (1994) 1070-1076
30. Blair J.C., Camacho-Hubner C., Miraki Moud F., et al. Standard and low-dose IGF-I generation test and spontaneous growth hormone secretion in children with idiopathic short stature. Clin. Endocrinol. 60 2 (2004) 163-168
31. Salerno M., Balestrieri B., Matrecano E., et al. Abnormal GH receptor signaling in children with idiopathic short stature. J. Clin. Endocrinol. Metab. 86 8 (2001) 3882-3888
32. Fukuda I., Hizuka N., Itoh E., et al. Acid-labile subunit in growth hormone excess and deficiency in adults: evaluation of its diagnostic value in comparison with insulin-like growth factor (IGF-I) and IGF-binding protein-3. Endocrinol. J. 49 3 (2002) 379-386
33. Barrios V., Argente J., Munoz M.T., Pozo J., Chowen J.A., and Hernandez M. Diagnostic interest of acid-labile subunit measurement in relationship to other components of the IGF system in pediatric patients with growth or eating disorders. Eur. J. Endocrinol. 144 3 (2001) 245-250
34. Collett-Solberg P.F., Pessoa de Queiroz A.N., Cardoso M.E., Jusan R.C., Vaisman M., and Guimaraes M.M. The correlation of the IGF-I, IGFBP-3, and ALS generation test to height velocity after 6 months of recombinant growth hormone therapy in girls with Turner syndrome. Growth Horm. IGF Res. 16 4 (2006) 240-246
35. Blair J.C., Camacho-Hubner C., Miraki Moud F., et al. Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature. Clin. Endocrinol. 60 (2004) 163-168
36. Dos Santos C., Essioux L., Teinturier C., Tauber M., Goffin V., and Bougnères P. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat. Genet. 36 (2004) 720-724
37. Binder G., Baur F., Schweizer R., and Ranke M.B. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. J. Clin. Endocrinol. Metab. 91 (2006) 659-664